Close
CDMO Safety Testing 2026
Novotech

ChargePoint Technology Acquires PuroVaso

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

eschbach Unveils Seqonis Intelligent Operations Platform

eschbach has renamed its flagship enterprise software platform, Shiftconnector,...

Agilent, Veeda Lifesciences Launch Biopharma Analytics Hub

Agilent Technologies and Veeda Lifesciences have announced a strategic...

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been...
- Advertisement -

ChargePoint Technology Group, the powder and liquid transfer specialist and a portfolio company of Arcline Investment Management, has announced the acquisition of PuroVaso, a leader in the design, development, and manufacture of single-use containers, handling equipment and accessories for the pharma, biopharma and life science markets.

Combined with the ChargePoint Technology portfolio of containment and sterile transfer technology, PuroVaso complements the existing product range, giving pharmaceutical manufacturers a broader choice of world-class powder and liquid transfer, storage, and handling products that solve customersโ€™ application specific problems with enhanced productivity.

Founded in 2016, PuroVaso has developed an intelligently designed and innovative range of containers, handling equipment, and accessories to exacting quality standards. The companyโ€™s single-use solutions are fully validated and used in many pharma, biopharma and life science customersโ€™ facilities globally.

“PuroVaso has vast technical expertise in pharmaceutical processing, transfer, handling and storage, with a broad portfolio of products that customers rely on for critical process applications,โ€ saidย Chris Eccles, CEO of ChargePoint. โ€œWith its extensive process knowledge, application engineered solutions and relentless customer focus, PuroVaso offers leading solutions to highly regulated pharma and biopharma landscapes along with several other process critical markets. We are very excited to have PuroVaso join the ChargePoint portfolio of solutions.โ€

Steve Boswell, Co-founder and Director of PuroVaso commented: โ€œWe are very proud to have developed a handling solution that provides an altogether improved and sustainable approach to handling powders.ย Now is the time to allow the PuroVaso product line to reach its true potential with ChargePoint.”

Fellow Co-founder, and Director Duncan Betteley added “The PuroVaso product is a very good fit for the existingย ChargePoint products.ย The ChargePoint team ย ย ย ย ย showed a real understanding for the products and a passion to want to take PuroVaso to the next stage of its development.ย ย We are confident that they are the right organisation to support existing customers and stakeholders, and we look forward to seeing PuroVaso continue to grow internationally under their stewardship.โ€

Steve Boswell and Duncan Betteley will not be joining ChargePoint as part of the PuroVaso acquisition. With S3 Process Limited they will however continue as an OEM supplier of the PuroVaso product line in combination with the solutions they supply into the U.K. market.

ChargePoint was advised on the deal by Eversheds Sutherland (led by Lizzy Tindall and Chris Archer). PuroVaso was advised by Keelys LLP (led by Hitesh Punjani).

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

eschbach Unveils Seqonis Intelligent Operations Platform

eschbach has renamed its flagship enterprise software platform, Shiftconnector,...

Agilent, Veeda Lifesciences Launch Biopharma Analytics Hub

Agilent Technologies and Veeda Lifesciences have announced a strategic...

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been...

Cantex and Headlamp Target MS Depression Using Lumos AI

Cantex Pharmaceuticals and Headlamp Health have entered a collaboration...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป